+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Spatial Genomics & Transcriptomics Market - Global Forecast to 2030- Product Image
Spatial Genomics & Transcriptomics Market - Global Forecast to 2030- Product Image
Sale

Spatial Genomics & Transcriptomics Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012040
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Spatial Genomics & Transcriptomics Market grew from USD 1.18 billion in 2024 to USD 1.32 billion in 2025. It is expected to continue growing at a CAGR of 12.39%, reaching USD 2.38 billion by 2030.

The convergence of spatial genomics and transcriptomics is transforming our understanding of biological systems by mapping gene expression within the native architecture of tissues. Recent advances in high-resolution imaging, microfluidics and sequencing chemistries have accelerated the transition from traditional bulk analyses to spatially resolved assays that capture molecular detail at single-cell and subcellular scales. This approach offers unparalleled insights into cellular heterogeneity, tissue microenvironments and disease progression. As researchers pursue applications in oncology, immunology and neuroscience, the demand for integrated solutions spanning consumables, instruments and analytical software continues to rise. Today's executive summary delivers a holistic overview of the current landscape, explores emerging shifts in technology and regulation, assesses the impact of recent trade policies, and surfaces strategic implications for market participants. By synthesizing segmentation, regional dynamics and competitor positioning, this document equips decision-makers with actionable intelligence to guide investment, partnership and product development strategies in this rapidly evolving arena.

Transformative Shifts Redefining the Field

The field is experiencing transformative shifts driven by technological convergence, computational breakthroughs and evolving research priorities. First, the integration of multiomics is merging spatial transcriptomics with proteomics and epigenomics in a single workflow, unlocking comprehensive molecular maps that reveal complex cellular interactions. Next, artificial intelligence-powered image analysis and pattern recognition are automating feature detection, accelerating data processing and improving reproducibility. High-throughput sequencing platforms now deliver hundreds of thousands of spatial barcodes per run, enabling researchers to scale from pilot studies to large cohort analyses without sacrificing resolution.

Meanwhile, open-source software ecosystems and cloud-based data management are democratizing access to computational pipelines, fostering collaboration across academic, clinical and industrial settings. Emerging in situ sequencing modalities, such as multiplexed error-robust fluorescence in situ hybridization and Slide-seq, are pushing detection sensitivity beyond traditional limits. Together these developments are expanding applications-from oncology profiling and tumor microenvironment analysis into developmental biology and neurodegenerative disease research-while driving down per-sample costs and reducing time to insight.

Cumulative Impact of United States Tariffs 2025 on the Ecosystem

In 2025, new tariffs imposed on a broad range of laboratory consumables, instruments and reagents have reshaped global supply chains and pricing structures. Researchers reliant on imported assay kits and high-precision microscopes faced higher unit costs, prompting many end-users to reassess sourcing strategies. Pharmaceutical and biotechnology companies have accelerated domestic manufacturing partnerships to mitigate exposure, while academic institutions have turned to alternate suppliers for key antibodies and sequencing platforms.

These measures have triggered a ripple effect through procurement cycles, with budget reallocation toward modular, locally produced sequencing platforms and open-architecture microscopes. Software providers have adapted licensing models to offset hardware price increases, often bundling analytics subscriptions with instrument sales. As a result, R&D timelines have tightened, and project prioritization has become more critical. To maintain momentum, stakeholders are investing in strategic inventory reserves, evaluating hybrid sourcing from Asia-Pacific and reinforcing long-term supply agreements-ensuring continuity in biological discovery despite evolving trade regulations.

Key Segmentation Insights Driving Market Dynamics

Market dynamics reflect a diverse product landscape, where consumables-comprising assay kits and reagents-remain essential for spatial transcriptomics workflows, driving recurring revenue and innovation in labeling chemistries. Instruments span advanced fluorescence and confocal microscopes alongside sequencing platforms that deliver spatially indexed reads at scale. Equally pivotal, data analysis platforms and visualization tools bridge raw sequencing output and actionable discovery, with cloud-native architectures enabling seamless integration of spatial gene expression data.

Sequencing methods under evaluation include classic in situ sequencing and multiplexed error-robust fluorescence in situ hybridization alongside newer approaches such as sequential fluorescence in situ hybridization, Slide-seq and dedicated spatial transcriptomics systems, each chosen based on resolution, throughput and tissue compatibility requirements. Applications range from cancer research-focusing on oncology profiling and tumor microenvironment analysis-to developmental biology, drug discovery through biomarker analysis and therapeutic target identification, immunology and neurology. End-users encompass academic biology departments and genomics centers, clinical research organizations, pharmaceutical and biotechnology firms, and research laboratories, including core facilities and private labs, all prioritizing throughput, data quality and cost efficiency.

Regional Market Dynamics and Growth Patterns

Regional dynamics highlight three core growth arenas. The Americas capitalize on robust R&D funding and established genomics centers, fostering rapid adoption of integrated spatial omics platforms. A thriving ecosystem of startups and service providers anchors market expansion, while streamlined regulatory pathways support clinical validation. In Europe, the Middle East and Africa, cross-border collaborations and standardization initiatives encourage harmonized protocols, yet diverse regulatory landscapes and reimbursement frameworks pose implementation challenges. Academic consortia and public-private partnerships are accelerating technology validation, particularly in oncology and immunology. Asia-Pacific emerges as a high-velocity growth region, propelled by government-led genomics initiatives, local manufacturing capacity and a burgeoning biotech sector. Investments in domestic reagent production and instrument assembly are reducing dependency on imports, while regional R&D centers drive tailored solutions for endemic diseases.

Leading Companies Shaping Innovation Trajectories

Industry leaders are shaping innovation through differentiated portfolios and strategic alliances. 10x Genomics and Illumina dominate with end-to-end platforms that integrate sample preparation, sequencing and analysis. Thermo Fisher Scientific extends its reach through reagent kits and open-system microscopes, while Danaher and Agilent Technologies reinforce their positions via service networks and modular instrument lines. Akoya Biosciences and RareCyte specialize in high-plex imaging, enhancing multiplex immunofluorescence capabilities. Bio-Techne and Bio-Rad Laboratories focus on next-generation reagents and single-molecule detection kits, whereas Resolve Biosciences and Vizgen push spatial transcriptomics sensitivity to new limits. Standard BioTools and Bruker leverage single-cell multiomics, and Carl Zeiss emphasizes super-resolution microscopy. Emerging players like Indica Labs and Seven Bridges Genomics drive software innovation in digital pathology and AI-driven analytics, while PerkinElmer, Merck KGaA and Ultivue expand global distribution and regulatory support.

Actionable Recommendations for Industry Leadership

To maintain competitive advantage and capitalize on emerging opportunities, organizations should diversify supply chains by qualifying multiple reagent and instrument vendors, thereby reducing exposure to tariff-driven price fluctuations. Investing in interoperable platforms that support both in situ sequencing and high-plex fluorescence assays will enable seamless multiomics expansion. Collaborations with cloud providers and AI specialists can accelerate data analysis workflows and enhance predictive modeling. Engaging early with regulatory bodies and participating in standards consortia will streamline clinical translation and reproducibility. Additionally, developing modular licensing models and training programs can foster user adoption and generate recurring revenue. Finally, forging partnerships with regional manufacturing hubs in Asia-Pacific and Europe will secure resilient production pipelines, ensuring uninterrupted access to critical consumables and instruments.

Conclusion: Navigating the Path Forward

Spatial genomics and transcriptomics stand at the forefront of precision biology, offering transformative insights that bridge basic research and clinical discovery. By understanding the interplay between technology advancements, trade policies and regional market nuances, stakeholders can navigate complexity and accelerate value creation. Strategic segmentation across product types, sequencing modalities, applications and end-user categories provides a roadmap for targeted investment and innovation. Aligning business models with regulatory landscapes and forging cross-sector collaborations will bolster resilience against geopolitical shifts. As the field matures, prioritizing interoperability, scalability and user-centric support will be critical for sustained growth and scientific impact.

Market Segmentation & Coverage

This research report categorizes the Spatial Genomics & Transcriptomics Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Consumables
    • Assay Kits
    • Reagents
  • Instruments
    • Microscopes
    • Sequencing Platforms
  • Software
    • Data Analysis Platforms
    • Visualization Tools
  • In Situ Sequencing
  • Multiplexed Error-Robust Fluorescence In Situ Hybridization
  • Sequential Fluorescence In Situ Hybridization
  • Slide-seq
  • Spatial Transcriptomics
  • Cancer Research
    • Oncology Profiling
    • Tumor Microenvironment Analysis
  • Developmental Biology
  • Drug Discovery
    • Biomarker Analysis
    • Therapeutic Target Identification
  • Immunology
  • Neurology
  • Academic Research Institutions
    • Biology Departments
    • Genomics Centers
  • Clinical Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Research Laboratories
    • Core Facilities
    • Private Labs

This research report categorizes the Spatial Genomics & Transcriptomics Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • Massachusetts
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Spatial Genomics & Transcriptomics Market to delves into recent significant developments and analyze trends in each of the following companies:

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Akoya Biosciences, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Bruker Corporation
  • Carl Zeiss AG
  • Danaher Corporation
  • Evident Corporation
  • Illumina, Inc.
  • Indica Labs, Inc.
  • Ionpath, Inc.
  • Merck KGaA
  • Parse Biosciences
  • PerkinElmer, Inc.
  • RareCyte, Inc.
  • Rebus Biosystems, Inc.
  • Resolve Biosciences GmbH.
  • S2 Genomics, Inc.
  • Seven Bridges Genomics
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
  • Ultivue, Inc.
  • Vizgen Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Spatial Genomics & Transcriptomics Market, by Product
8.1. Introduction
8.2. Consumables
8.2.1. Assay Kits
8.2.2. Reagents
8.3. Instruments
8.3.1. Microscopes
8.3.2. Sequencing Platforms
8.4. Software
8.4.1. Data Analysis Platforms
8.4.2. Visualization Tools
9. Spatial Genomics & Transcriptomics Market, by Sequencing Method
9.1. Introduction
9.2. In Situ Sequencing
9.3. Multiplexed Error-Robust Fluorescence In Situ Hybridization
9.4. Sequential Fluorescence In Situ Hybridization
9.5. Slide-seq
9.6. Spatial Transcriptomics
10. Spatial Genomics & Transcriptomics Market, by Application
10.1. Introduction
10.2. Cancer Research
10.2.1. Oncology Profiling
10.2.2. Tumor Microenvironment Analysis
10.3. Developmental Biology
10.4. Drug Discovery
10.4.1. Biomarker Analysis
10.4.2. Therapeutic Target Identification
10.5. Immunology
10.6. Neurology
11. Spatial Genomics & Transcriptomics Market, by End-User
11.1. Introduction
11.2. Academic Research Institutions
11.2.1. Biology Departments
11.2.2. Genomics Centers
11.3. Clinical Research Organizations
11.4. Pharmaceutical & Biotechnology Companies
11.5. Research Laboratories
11.5.1. Core Facilities
11.5.2. Private Labs
12. Americas Spatial Genomics & Transcriptomics Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Spatial Genomics & Transcriptomics Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Spatial Genomics & Transcriptomics Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. 10x Genomics, Inc.
15.3.2. Agilent Technologies, Inc.
15.3.3. Akoya Biosciences, Inc.
15.3.4. Becton, Dickinson and Company
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. Bio-Techne Corporation
15.3.7. Bruker Corporation
15.3.8. Carl Zeiss AG
15.3.9. Danaher Corporation
15.3.10. Evident Corporation
15.3.11. Illumina, Inc.
15.3.12. Indica Labs, Inc.
15.3.13. Ionpath, Inc.
15.3.14. Merck KGaA
15.3.15. Parse Biosciences
15.3.16. PerkinElmer, Inc.
15.3.17. RareCyte, Inc.
15.3.18. Rebus Biosystems, Inc.
15.3.19. Resolve Biosciences GmbH.
15.3.20. S2 Genomics, Inc.
15.3.21. Seven Bridges Genomics
15.3.22. Standard BioTools Inc.
15.3.23. Thermo Fisher Scientific Inc.
15.3.24. Ultivue, Inc.
15.3.25. Vizgen Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET MULTI-CURRENCY
FIGURE 2. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET MULTI-LANGUAGE
FIGURE 3. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY VISUALIZATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IN SITU SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MULTIPLEXED ERROR-ROBUST FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENTIAL FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SLIDE-SEQ, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ONCOLOGY PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TUMOR MICROENVIRONMENT ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOMARKER ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY THERAPEUTIC TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOLOGY DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY GENOMICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CORE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRIVATE LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 82. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 84. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 85. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 86. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 87. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 89. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 90. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 92. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 93. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 95. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 98. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 100. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 101. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 103. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 139. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 141. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 142. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 143. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 144. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 146. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 147. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 149. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 150. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 152. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 153. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 154. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 155. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 157. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 158. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 160. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 161. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 172. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 174. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 175. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 176. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 177. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 179. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 180. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 182. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 183. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 187. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 194. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 197. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 198. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 205. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 207. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 208. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 209. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 215. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 216. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 218. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 219. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 220. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 226. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 227. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 238. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 239. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 240. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 241. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 242. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 243. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 245. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 246. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 248. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 249. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 251. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 252. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 253. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 257. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 259. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 272. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 273. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 274. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 275. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 276. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 277. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 279. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 280. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 282. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 283. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 284. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 285. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 286. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 287. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 288. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 290. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 291. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 292. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 201

Companies Mentioned

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Akoya Biosciences, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Bruker Corporation
  • Carl Zeiss AG
  • Danaher Corporation
  • Evident Corporation
  • Illumina, Inc.
  • Indica Labs, Inc.
  • Ionpath, Inc.
  • Merck KGaA
  • Parse Biosciences
  • PerkinElmer, Inc.
  • RareCyte, Inc.
  • Rebus Biosystems, Inc.
  • Resolve Biosciences GmbH.
  • S2 Genomics, Inc.
  • Seven Bridges Genomics
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
  • Ultivue, Inc.
  • Vizgen Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Spatial Genomics and Transcriptomics Market Report and Forecast 2024-2032 - Product Image

Spatial Genomics and Transcriptomics Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Spatial Transcriptomics & Genomics Market - Global Outlook & Forecast 2025-2030 - Product Image

Spatial Transcriptomics & Genomics Market - Global Outlook & Forecast 2025-2030

  • Report
  • 362 Pages
  • Global
From
Spatial Genomics & Transcriptomics Market by Product (Instruments, Consumables, Services), Technique (Transcriptomics (IHC, ISH), Genomics (LCM), Service Type (Sample Prep, Sequencing), Application (Translation Research (Cancer)) - Global Forecast to 2029 - Product Image

Spatial Genomics & Transcriptomics Market by Product (Instruments, Consumables, Services), Technique (Transcriptomics (IHC, ISH), Genomics (LCM), Service Type (Sample Prep, Sequencing), Application (Translation Research (Cancer)) - Global Forecast to 2029

  • Report
  • 450 Pages
  • Global
From
Spatial Genomics and Transcriptomics - Global Strategic Business Report - Product Image

Spatial Genomics and Transcriptomics - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Spatial Genomics and Transcriptomics Market - A Global and Regional Analysis: Focus on Product Type, Sample Type, Workflow, Application, End User, and Region - Analysis and Forecast, 2024-2034 - Product Image

Spatial Genomics and Transcriptomics Market - A Global and Regional Analysis: Focus on Product Type, Sample Type, Workflow, Application, End User, and Region - Analysis and Forecast, 2024-2034

  • Report
  • 115 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.